117 related articles for article (PubMed ID: 8483323)
21. 2',5'-Oligoadenylate synthetase levels in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b do not correlate with clinical response.
Millar BC; Bell JB
Br J Cancer; 1995 Dec; 72(6):1525-30. PubMed ID: 8519671
[TBL] [Abstract][Full Text] [Related]
22. Growth inhibition of human acute promyelocytic leukemia NB-4 cells by interferons and all-trans retinoic acid: trans-modulation of inducible gene expression pathways.
Kumar R; Korutla L
Anticancer Res; 1995; 15(2):353-60. PubMed ID: 7763006
[TBL] [Abstract][Full Text] [Related]
23. Enhancement by retinoic acid and dibutyryl cyclic adenosine 3':5'-monophosphate of the differentiation and gene expression of human neuroblastoma cells induced by interferon.
Higuchi T; Hannigan GE; Malkin D; Yeger H; Williams BR
Cancer Res; 1991 Aug; 51(15):3958-64. PubMed ID: 1677311
[TBL] [Abstract][Full Text] [Related]
24. Induction of 2',5'-oligoadenylate synthetase by retinoic acid in two transformed human cell lines.
Bourgeade MF; Besançon F
Cancer Res; 1984 Nov; 44(11):5355-60. PubMed ID: 6435868
[TBL] [Abstract][Full Text] [Related]
25. Combined effects of interferon and 2'-deoxycoformycin on 2',5'-oligoadenylate synthetase and adenosine deaminase in hairy cell and chronic lymphocytic leukemia cells.
Triozzi PL; Avery KA; Grever MR; Kraut EH
J Interferon Res; 1990 Oct; 10(5):535-40. PubMed ID: 2273300
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic study of a human recombinant interferon (Re-IFN-alpha A) in cynomolgus monkeys by 2'-5' oligoadenylate synthetase assay.
Bannai H; Tatsumi M; Kohase M; Onishi E; Yamazaki S
Jpn J Med Sci Biol; 1985 Jun; 38(3):113-24. PubMed ID: 2999483
[TBL] [Abstract][Full Text] [Related]
27. Clinical and laboratory changes induced by alpha interferon in chronic lymphocytic leukemia--a pilot study.
Talpaz M; Rosenblum M; Kurzrock R; Reuben J; Kantarjian H; Gutterman J
Am J Hematol; 1987 Apr; 24(4):341-50. PubMed ID: 3494396
[TBL] [Abstract][Full Text] [Related]
28. Role of interferon and 2',5'-oligoadenylate synthetase in erythroid differentiation of Friend leukemia cells. Studies with interferon-sensitive and -resistant variants.
Mechti N; Affabris E; Romeo G; Lebleu B; Rossi GB
J Biol Chem; 1984 Mar; 259(5):3261-5. PubMed ID: 6321503
[TBL] [Abstract][Full Text] [Related]
29. Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle.
Schiller JH; Horisberger MA; Bittner G; Carlin JM; Storer B; Byrne GI; Willson JK; Borden EC
J Biol Response Mod; 1990 Aug; 9(4):368-77. PubMed ID: 2395002
[TBL] [Abstract][Full Text] [Related]
30. Interferon-independent activation of (2'-5') oligoadenylate synthetase in Friend erythroleukemia cell variants exposed to HMBA.
Salzberg S; Heller A; Zou JP; Collart FR; Huberman E
J Cell Sci; 1996 Jun; 109 ( Pt 6)():1517-26. PubMed ID: 8799838
[TBL] [Abstract][Full Text] [Related]
31. Interferon-induced cytotoxicity and (2'-5') oligo(A) synthetase activity in T cells. Differences in responsiveness among T cells from various individuals and among lymphoblastoid T-cell lines.
Gazitt Y; Ben-Bassat H; Wallach D; Revel M; Schattner A
Clin Immunol Immunopathol; 1984 Jan; 30(1):71-9. PubMed ID: 6607796
[TBL] [Abstract][Full Text] [Related]
32. 2'-5'-oligoadenylate synthetase gene expression in normal and murine sarcoma virus-transformed NIH 3T3 cells.
David S; Nissim A; Chebath J; Salzberg S
J Virol; 1989 Mar; 63(3):1116-22. PubMed ID: 2536824
[TBL] [Abstract][Full Text] [Related]
33. Interferon-stimulated genes in interferon-sensitive and -resistant chronic myelogenous leukemia patients.
Talpaz M; Chernajovsky Y; Troutman-Worden K; Wetzler M; Kantarjian H; Gutterman JU; Kurzrock R
Cancer Res; 1992 Mar; 52(5):1087-90. PubMed ID: 1737366
[TBL] [Abstract][Full Text] [Related]
34. Different mechanisms for activation of gene transcription by interferons alpha and gamma.
Faltynek CR; McCandless S; Chebath J; Baglioni C
Virology; 1985 Jul; 144(1):173-80. PubMed ID: 3933177
[TBL] [Abstract][Full Text] [Related]
35. Expression of interferon-induced genes in different tissues of mice.
Flenniken AM; Galabru J; Rutherford MN; Hovanessian AG; Williams BR
J Virol; 1988 Sep; 62(9):3077-83. PubMed ID: 2969982
[TBL] [Abstract][Full Text] [Related]
36. Effect of recombinant alpha-interferon on the expression of the bcr-abl fusion gene in human chronic myelogenous human leukemia cell lines.
Andrews DF; Singer JW; Collins SJ
Cancer Res; 1987 Dec; 47(24 Pt 1):6629-32. PubMed ID: 3479248
[TBL] [Abstract][Full Text] [Related]
37. Modulation of nuclear proto-oncogene expression and cellular growth in myeloid leukemic cells by human interferon alpha.
Marshall AH; Alper D; Hiscott J
J Cell Physiol; 1988 May; 135(2):324-31. PubMed ID: 3163696
[TBL] [Abstract][Full Text] [Related]
38. Recombinant human interferon alpha-2 and juvenile chronic myelogenous leukemia: cell receptor binding, enzymatic induction, and growth suppression in vitro.
Estrov Z; Lau AS; Williams BR; Freedman MH
Exp Hematol; 1987 Feb; 15(2):127-32. PubMed ID: 3102273
[TBL] [Abstract][Full Text] [Related]
39. Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis.
Neubauer A; Fiebeler A; Graham DK; O'Bryan JP; Schmidt CA; Barckow P; Serke S; Siegert W; Snodgrass HR; Huhn D
Blood; 1994 Sep; 84(6):1931-41. PubMed ID: 7521695
[TBL] [Abstract][Full Text] [Related]
40. Reconstitution of endogenous interferon a by recombinant interferon in hairy cell leukemia.
Shehata M; Schwarzmeier JD; Nguyen ST; Hilgarth M; Berger R; Hubmann R; Kickmaier S; Decker T
Cancer Res; 2000 Oct; 60(19):5420-6. PubMed ID: 11034083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
